Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, have an estimated market size of US$ 177 million for twelve months ending Sep 2022
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
Fulvestrant Injection, 250 mg/5 mL, has an estimated market size of US $71 million for twelve months ending Sep 2022 according to IQVIA
Subscribe To Our Newsletter & Stay Updated
